Evaluation of the Utility of an EEC for Assessing Efficacy of SIT in Pivotal Clinical Trials

NCT02297490 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

158

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated due to the interim Analysis results indicating a weaker correlation than anticipated and reported by other study groups.

Conditions

Allergic Rhinoconjunctivitis
Healthy Volunteers

Interventions

DRUG: Placebo
BIOLOGICAL: Allergovit 6-grasses

Sponsor

Allergopharma GmbH & Co. KG

Collaborators

[object Object]